Order Article Reprints

Unterrainer LM, Beyer L, Zacherl MJ, Gildehaus FJ, Todica A, Kunte SC, Holzgreve A, Sheikh GT, Herlemann A, Casuscelli J, et al. Total Tumor Volume on ¹⁸F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with ²²⁵Ac-PSMA-I&T. Biomedicines. 2022; 10(5):946. https://doi.org/10.3390/biomedicines10050946

Unterrainer, Lena M., Leonie Beyer, Mathias J. Zacherl, Franz J. Gildehaus, Andrei Todica, Sophie C. Kunte, Adrien Holzgreve, Gabriel T. Sheikh, Annika Herlemann, Jozefina Casuscelli, and et al. 2022. "Total Tumor Volume on ¹⁸F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with ²²⁵Ac-PSMA-I&T" Biomedicines 10, no. 5: 946. https://doi.org/10.3390/biomedicines10050946

Unterrainer, L. M., Beyer, L., Zacherl, M. J., Gildehaus, F. J., Todica, A., Kunte, S. C., Holzgreve, A., Sheikh, G. T., Herlemann, A., Casuscelli, J., Brendel, M., Albert, N. L., Wenter, V., Schmidt-Hegemann, N.-S., Kunz, W. G., Cyran, C. C., Ricke, J., Stief, C. G., Bartenstein, P., ... Unterrainer, M. (2022). Total Tumor Volume on ¹⁸F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with ²²⁵Ac-PSMA-I&T. Biomedicines, 10(5), 946. https://doi.org/10.3390/biomedicines10050946